NCT00823693已完成2 期
Multi-center, Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Safety and Efficacy of Bimosiamose 5% Cream for the Treatment of Patients With Chronic Plaque Type Psoriasis
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 107
- 试验地点
- 1
研究概览
简要总结
The purpose of this study is to determine whether Bimosiamose Cream is safe and effective in the treatment of plaque type psoriasis.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Clinical diagnosis of plaque type psoriasis PASI score of 5-15
- •At least 18 years of age
- •Written informed consent
排除标准
- •Active skin infection
- •More than 20% Body Surface Area (BSA) affected by psoriasis
- •Use of certain anti-psoriasis medication or treatments
研究组 & 干预措施
Bimosiamose Cream
Active Comparator
干预措施: Bimosiamose Cream (Drug)
Placebo Cream
Placebo Comparator
干预措施: Placebo Cream (Drug)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Study to Evaluate Safety and Efficacy of Inhaled Bimosiamose for the Treatment of Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)Chronic Obstructive Pulmonary DiseaseNCT01108913Revotar Biopharmaceuticals AG60
已完成
3 期
Safety and Effectiveness Study of Actinic Keratosis Treatment Following CryosurgeryActinic KeratosisNCT00894647Graceway Pharmaceuticals, LLC247
已完成
3 期
Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital WartsGenital WartsNCT00674739Graceway Pharmaceuticals, LLC470
Unknown
不适用
Efficacy and Safety of Benvitimod Cream in the Retreatment of Mild to Moderate PsoriasisPsoriasisNCT05326659Peking University People's Hospital390
已完成
3 期
A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25)Acne VulgarisNCT02608450Cassiopea SpA708